10x Genomics (TXG) Change in Cash (2018 - 2026)

10x Genomics' Change in Cash history runs 9 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• In Q1 2026, Change in Cash fell 50.54% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $113.2 million (up 432.07% YoY), while the FY2025 annual figure was $129.9 million, up 953.64% from the prior year.
• Change in Cash came in at $16.3 million for Q1 2026 at 10x Genomics, down from $41.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $112.4 million in Q1 2023 to a low of -$276.0 million in Q1 2022.
• A 5-year average of -$6.2 million and a median of $16.3 million in 2026 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash sank 906.61% in 2022 and jumped 1041.88% in 2025, its largest moves.
• 10x Genomics' Change in Cash stood at -$14.2 million in 2022, then surged by 413.77% to $44.5 million in 2023, then sank by 221.43% to -$54.1 million in 2024, then jumped by 176.27% to $41.3 million in 2025, then slumped by 60.45% to $16.3 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $16.3 million, $41.3 million, and $35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison